Id |
Subject |
Object |
Predicate |
Lexical cue |
TextSentencer_T1 |
0-70 |
Sentence |
denotes |
Molecular characterization of a unique von Willebrand disease variant. |
TextSentencer_T2 |
71-144 |
Sentence |
denotes |
A novel mutation affecting von Willebrand factor/factor VIII interaction. |
TextSentencer_T3 |
145-361 |
Sentence |
denotes |
von Willebrand factor (vWF) plays a central role in blood coagulation, mediating the adhesion of the initial platelet plug to the subendothelium, and serving as the carrier for factor VIII (FVIII) in the circulation. |
TextSentencer_T4 |
362-625 |
Sentence |
denotes |
In previous studies, we have mapped the epitope for an anti-vWF monoclonal antibody which inhibits the interaction between FVIII and vWF to a region spanning Thr78 to Thr96 of the mature protein (Bahou, W.F., Ginsburg, D., Sikkink, R., Litwiller, R., and Fass, D. |
TextSentencer_T5 |
626-638 |
Sentence |
denotes |
N. (1989) J. |
TextSentencer_T6 |
639-644 |
Sentence |
denotes |
Clin. |
TextSentencer_T7 |
645-652 |
Sentence |
denotes |
Invest. |
TextSentencer_T8 |
653-664 |
Sentence |
denotes |
84, 56-61). |
TextSentencer_T9 |
665-778 |
Sentence |
denotes |
We now report the identification of a mutation within this region of vWF that results in decreased FVIII binding. |
TextSentencer_T10 |
779-1038 |
Sentence |
denotes |
Sequence analysis of polymerase chain reaction amplified platelet vWF mRNA from a von Willebrand disease (vWD) patient with a disproportionately low FVIII level identified a single nucleotide substitution (G----A), resulting in the conversion of Arg91----Gln. |
TextSentencer_T11 |
1039-1221 |
Sentence |
denotes |
Recombinant vWF carrying this substitution showed decreased binding to FVIII compared with wild-type vWF or vWF carrying a polymorphic substitution in the same region (Arg89----Gln). |
TextSentencer_T12 |
1222-1413 |
Sentence |
denotes |
These observations suggest a critical role for Arg91 in the interaction of vWF with FVIII and identify the molecular mechanism for a variant of vWD associated with unusually low FVIII levels. |
T1 |
0-70 |
Sentence |
denotes |
Molecular characterization of a unique von Willebrand disease variant. |
T2 |
71-144 |
Sentence |
denotes |
A novel mutation affecting von Willebrand factor/factor VIII interaction. |
T3 |
145-361 |
Sentence |
denotes |
von Willebrand factor (vWF) plays a central role in blood coagulation, mediating the adhesion of the initial platelet plug to the subendothelium, and serving as the carrier for factor VIII (FVIII) in the circulation. |
T4 |
362-625 |
Sentence |
denotes |
In previous studies, we have mapped the epitope for an anti-vWF monoclonal antibody which inhibits the interaction between FVIII and vWF to a region spanning Thr78 to Thr96 of the mature protein (Bahou, W.F., Ginsburg, D., Sikkink, R., Litwiller, R., and Fass, D. |
T5 |
626-638 |
Sentence |
denotes |
N. (1989) J. |
T6 |
639-644 |
Sentence |
denotes |
Clin. |
T7 |
645-652 |
Sentence |
denotes |
Invest. |
T8 |
653-664 |
Sentence |
denotes |
84, 56-61). |
T9 |
665-778 |
Sentence |
denotes |
We now report the identification of a mutation within this region of vWF that results in decreased FVIII binding. |
T10 |
779-1038 |
Sentence |
denotes |
Sequence analysis of polymerase chain reaction amplified platelet vWF mRNA from a von Willebrand disease (vWD) patient with a disproportionately low FVIII level identified a single nucleotide substitution (G----A), resulting in the conversion of Arg91----Gln. |
T11 |
1039-1221 |
Sentence |
denotes |
Recombinant vWF carrying this substitution showed decreased binding to FVIII compared with wild-type vWF or vWF carrying a polymorphic substitution in the same region (Arg89----Gln). |
T12 |
1222-1413 |
Sentence |
denotes |
These observations suggest a critical role for Arg91 in the interaction of vWF with FVIII and identify the molecular mechanism for a variant of vWD associated with unusually low FVIII levels. |